- Home
- PRTA vs DNUT Comparison
PRTA vs DNUT Comparison
Compare PRTA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- DNUT
- Stock Information
- Founded
- PRTA 2012
- DNUT 1937
- Country
- PRTA Ireland
- DNUT United States
- Employees
- PRTA N/A
- DNUT N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- PRTA Health Care
- DNUT Consumer Staples
- Exchange
- PRTA Nasdaq
- DNUT Nasdaq
- Market Cap
- PRTA 809.8M
- DNUT N/A
- IPO Year
- PRTA N/A
- DNUT 2021
- Fundamental
- Price
- PRTA $12.14
- DNUT $4.95
- Analyst Decision
- PRTA Buy
- DNUT Buy
- Analyst Count
- PRTA 9
- DNUT 8
- Target Price
- PRTA $54.57
- DNUT $13.13
- AVG Volume (30 Days)
- PRTA 454.8K
- DNUT 3.3M
- Earning Date
- PRTA 05-07-2025
- DNUT 05-08-2025
- Dividend Yield
- PRTA N/A
- DNUT 2.89%
- EPS Growth
- PRTA N/A
- DNUT N/A
- EPS
- PRTA N/A
- DNUT 0.02
- Revenue
- PRTA $135,157,000.00
- DNUT $1,665,397,000.00
- Revenue This Year
- PRTA N/A
- DNUT $1.24
- Revenue Next Year
- PRTA $131.75
- DNUT $12.40
- P/E Ratio
- PRTA N/A
- DNUT $271.05
- Revenue Growth
- PRTA 47.92
- DNUT N/A
- 52 Week Low
- PRTA $11.42
- DNUT $4.78
- 52 Week High
- PRTA $25.42
- DNUT $16.05
- Technical
- Relative Strength Index (RSI)
- PRTA 38.46
- DNUT 29.19
- Support Level
- PRTA $11.42
- DNUT $4.78
- Resistance Level
- PRTA $13.52
- DNUT $5.59
- Average True Range (ATR)
- PRTA 0.75
- DNUT 0.24
- MACD
- PRTA -0.12
- DNUT 0.05
- Stochastic Oscillator
- PRTA 24.66
- DNUT 17.71
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).